CD38 and breast carcinoma: We performed overall survival (OS) analysis, and the results of survival analysis revealed that CD38, APOH, EPB42, and CADPS had significant impacts on breast cancer patients; the survival curves are shown in Fig. 5, with p values from the log-rank test of 0.034, 0.0039, 0.039, and 0.0012, respectively.